245 related articles for article (PubMed ID: 24514164)
1. Approach to invasive pulmonary aspergillosis in critically ill patients.
Koulenti D; Garnacho-Montero J; Blot S
Curr Opin Infect Dis; 2014 Apr; 27(2):174-83. PubMed ID: 24514164
[TBL] [Abstract][Full Text] [Related]
2. Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation.
Rodriguez-Goncer I; Thomas S; Foden P; Richardson MD; Ashworth A; Barker J; Geraghty CG; Muldoon EG; Felton TW
Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1251-1257. PubMed ID: 29623451
[TBL] [Abstract][Full Text] [Related]
3. Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment.
Vanderbeke L; Spriet I; Breynaert C; Rijnders BJA; Verweij PE; Wauters J
Curr Opin Infect Dis; 2018 Dec; 31(6):471-480. PubMed ID: 30299367
[TBL] [Abstract][Full Text] [Related]
4. Invasive Pulmonary Aspergillosis in Nonimmunocompromised Hosts.
Tudesq JJ; Peyrony O; Lemiale V; Azoulay E
Semin Respir Crit Care Med; 2019 Aug; 40(4):540-547. PubMed ID: 31585479
[TBL] [Abstract][Full Text] [Related]
5. [Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease].
Barberán J; Mensa J
Rev Iberoam Micol; 2014; 31(4):237-41. PubMed ID: 25481431
[TBL] [Abstract][Full Text] [Related]
6. Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures.
Paiva JA; Mergulhão P; Gomes A; Taccone FS; Van den Abeele AM; Bulpa P; Misset B; Meersseman W; Dimopoulos G; Rello J; Vogelaers D; Blot S
Int J Antimicrob Agents; 2017 Oct; 50(4):529-535. PubMed ID: 28669830
[TBL] [Abstract][Full Text] [Related]
7. Management of invasive aspergillosis in patients with COPD: rational use of voriconazole.
Ader F; Bienvenu AL; Rammaert B; Nseir S
Int J Chron Obstruct Pulmon Dis; 2009; 4():279-87. PubMed ID: 19684861
[TBL] [Abstract][Full Text] [Related]
8. Invasive pulmonary aspergillosis in critically ill patients with hematological malignancies.
Pardo E; Lemiale V; Mokart D; Stoclin A; Moreau AS; Kerhuel L; Calvet L; Valade S; De Jong A; Darmon M; Azoulay E
Intensive Care Med; 2019 Dec; 45(12):1732-1741. PubMed ID: 31599334
[TBL] [Abstract][Full Text] [Related]
9. Is Bulpa criteria suitable for the diagnosis of probable invasive pulmonary Aspergillosis in critically ill patients with chronic obstructive pulmonary disease? A comparative study with EORTC/ MSG and ICU criteria.
Huang L; He H; Jin J; Zhan Q
BMC Infect Dis; 2017 Mar; 17(1):209. PubMed ID: 28292284
[TBL] [Abstract][Full Text] [Related]
10. Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort study.
Delsuc C; Cottereau A; Frealle E; Bienvenu AL; Dessein R; Jarraud S; Dumitrescu O; Le Maréchal M; Wallet F; Friggeri A; Argaud L; Rimmelé T; Nseir S; Ader F
Crit Care; 2015 Dec; 19():421. PubMed ID: 26631029
[TBL] [Abstract][Full Text] [Related]
11. Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study.
Hoenigl M; Prattes J; Neumeister P; Wölfler A; Krause R
Mycoses; 2018 Mar; 61(3):201-205. PubMed ID: 29112326
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in invasive pulmonary aspergillosis.
Chai LY; Hsu LY
Curr Opin Pulm Med; 2011 May; 17(3):160-6. PubMed ID: 21252677
[TBL] [Abstract][Full Text] [Related]
13. Acute Invasive Pulmonary Aspergillosis: Clinical Presentation and Treatment.
Heylen J; Vanbiervliet Y; Maertens J; Rijnders B; Wauters J
Semin Respir Crit Care Med; 2024 Feb; 45(1):69-87. PubMed ID: 38211628
[TBL] [Abstract][Full Text] [Related]
14. Invasive Pulmonary Aspergillosis.
Ledoux MP; Guffroy B; Nivoix Y; Simand C; Herbrecht R
Semin Respir Crit Care Med; 2020 Feb; 41(1):80-98. PubMed ID: 32000286
[TBL] [Abstract][Full Text] [Related]
15. Invasive pulmonary aspergillosis in patients with solid tumours: risk factors and predictors of clinical outcomes.
Dandachi D; Wilson Dib R; Fernández-Cruz A; Jiang Y; Chaftari AM; Hachem R; Raad I
Ann Med; 2018 Dec; 50(8):713-720. PubMed ID: 30230385
[TBL] [Abstract][Full Text] [Related]
16. Fatal invasive pulmonary aspergillosis in non-immunocompromised host: A case report.
Ao W; Huang P; Wang J; Fu X; Fu B
Medicine (Baltimore); 2023 Oct; 102(43):e35702. PubMed ID: 37904478
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient.
Garnacho-Montero J; Olaechea P; Alvarez-Lerma F; Alvarez-Rocha L; Blanquer J; Galván B; Rodriguez A; Zaragoza R; Aguado JM; Mensa J; Solé A; Barberán J
Rev Esp Quimioter; 2013 Jun; 26(2):173-88. PubMed ID: 23817660
[TBL] [Abstract][Full Text] [Related]
19. Significance of Aspergillus spp. isolation from lower respiratory tract samples for the diagnosis and prognosis of invasive pulmonary aspergillosis in chronic obstructive pulmonary disease.
He HY; Chang S; Ding L; Sun B; Li F; Zhan QY
Chin Med J (Engl); 2012 Sep; 125(17):2973-8. PubMed ID: 22932166
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis.
Jung J; Kim MY; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
J Microbiol Immunol Infect; 2018 Dec; 51(6):802-809. PubMed ID: 28712819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
